Article Versions Notes

Chamcheu JC, Esnault S, Adhami VM, Noll AL, Banang-Mbeumi S, Roy T, Singh SS, Huang S, Kousoulas KG, Mukhtar H. Fisetin, a 3,7,3′,4′-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models. Cells. 2019; 8(9):1089. https://doi.org/10.3390/cells8091089

Chamcheu, Jean Christopher, Stephane Esnault, Vaqar M. Adhami, Andrea L. Noll, Sergette Banang-Mbeumi, Tithi Roy, Sitanshu S. Singh, Shile Huang, Konstantin G. Kousoulas, and Hasan Mukhtar. 2019. "Fisetin, a 3,7,3′,4′-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models" Cells 8, no. 9: 1089. https://doi.org/10.3390/cells8091089

Chamcheu, J. C., Esnault, S., Adhami, V. M., Noll, A. L., Banang-Mbeumi, S., Roy, T., Singh, S. S., Huang, S., Kousoulas, K. G., & Mukhtar, H. (2019). Fisetin, a 3,7,3′,4′-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models. Cells, 8(9), 1089. https://doi.org/10.3390/cells8091089